Abstract
Climate change is a global issue that has had significant impacts on public health and healthcare policy worldwide. The direct impact of climate change on healthcare has been associated with extreme weather events, resulting in a higher demand for disaster management resources and reduced healthcare access. Moreover, the increase of zoonotic spillover effects has increased the risk of transmission of different diseases, including COVID-19. The healthcare industry alone is responsible for 4.4% of greenhouse gas global emissions. The surgical theatre is a resource-intense healthcare activity and a major carbon emitter, thus surgical processes require rethinking. This article proposes the introduction of environmental-related outcome measures in clinical trials, which will associate highest clinical standards to a reduced impact of care on climate change. Breast cancer care may represent a model disease for the implementation of evidence-based protocols, such as Green Breast Surgery, aiming to optimize the carbon footprint of care without affecting oncological and non-oncological outcomes. Physicians and healthcare workers worldwide should be aware of the importance of addressing environmental issues in healthcare policy, implementing programs to reduce their carbon footprint, and contributing to a more sustainable future.
Keywords: Patient reported outcome measures, green breast surgery, climate change, breast neoplasm, COVID-19
Since the mid-eighteenth century, a steady increase of global temperature has been registered, especially between 1980s and 2020s, with an anomalous increase of nearly 1.00˚C in 2020. Climate change has been associated in the last years with an increase in the number of environmental events and disasters (1). Most scientists argue that the main cause of global warming is the anthropogenic emission of greenhouse gases (GHG) [e.g., carbon dioxide (CO2), methane (CH4), and nitrous oxide (N2O)] (Table I). In order to contain GHG emission and avoid global temperature increase >2.0˚, 196 delegates during the 21st United Nations Conference of the Parties on Climate Change COP21 in Paris agreed voluntarily to reduce their greenhouse emission. For instance, the European union aims to reduce its GHG emission by 50% before 2030 and reach carbon neutrality in 2050 (2). The GHG emission reduction is a part of the larger Sustainable Development Goals declared by United Nations (UN) in 2015 in addition to end poverty and enhance human lives (3). Whereas good health and well-being are reported as the third goal of this program, the UN underlined how global warming counteraction should not interfere with health care admission worldwide. To achieve these crucial goals, a tremendous effort must be made by every single citizen of the world.
Table I. Definition of non-medical terms to understand the green surgery protocol philosophy; the terms are enlisted as they appear in the text.
Climate change has a direct impact on global health care and health policy worldwide, mostly on the marginalized and lower income population. The higher rate of extreme weather events requires higher resources for disaster management, trauma, and mental health care, reducing health care resources assigned to elective and preventive measures (4,5). Direct economic damage is only a small part of the effect on heath care policy, only in 2021 253 billion US dollars were spent for disaster management especially in low Human Development Index (HDI) countries, where most of these expenses are covered directly by the population, potentially reducing health care access (6,7). Moreover, heat waves and direct heat exposure have been associated with a potential loss of 470 billion labor hours globally in 2021, equivalent to 0.72% of global economic output, and 5-6% of gross domestic product (GDP) in low HDI countries (6).
Besides economic side effects, a robust body of evidence demonstrates how GHG rising, heat waves, wildfires or other natural disaster may also affect public health by increasing the rate of cardiovascular diseases, respiratory disorders, allergies, and oncological diseases (8). While respiratory disorders (as asthma or Chronic obstructive pulmonary disease) may be easily associated with the inhalation of air pollutants, multiple cardiovascular effects have been recorded after exposure to air pollutants (9). Short-term exposure has been associated with hypertension, stroke, myocardial infarctions, and heart insufficiency, coronary atherosclerosis, ventricular hypertrophy are reported to occur in humans after long-time exposure to pollutants (10-12). Inflammation and long-term pollutant exposure have been related to psychosocial, neurological and skin disorders (13,14).
Moreover, a relationship has been reported between oncological diagnosis and climate change. An increased exposure to several carcinogenic agents has been associated with climate change (air pollution, chemical toxicants, ultraviolet radiation). Moreover, health behavior including the diet, physical activity, and sun protection may be impaired or modified by different consequences of climate change such as air pollution, chemical toxicants, ultraviolet radiation, food supply, and infections (15).
Additionally, the increase of zoonotic spillover effects is a well-documented consequence of the climate change. In fact, deforestation, urbanization, and width of the arid tropical edge plays a pivotal role in the expansion of the arthropod vector range for emerging diseases (16,17). For instance, health care policy is currently facing an increase of Vibrio pathogen transmission due to coastal water rising temperature worldwide, an increase of 31.3% of months suitable for Malaria spread in America, and an increase of dengue transmission by 12% in the same period (6). The climate change pressure to the health system due to zoonotic and emerging diseases is expected to rise also because of the coexistence of pandemics by different pathogens (e.g., COVID-19 and Dengue fever) in regions of South America, Asia, and Africa.
Under this perspective, COVID-19 pandemic represents the most famous example of zoonotic spillover (5,18). Declared pandemic in march 2020, COVID-19 had a strong effect on elective surgery and health care policy worldwide (19,20). Frail population, most of them requiring surgical or medical treatments, avoided hospital due to fear of cross infections and the higher perceived risk of mortality (21,22). For instance, during the pandemic a mean reduction of 48.4% in admissions for acute myocardial failure was reported in Italy when compared with the previous year and up to 40% of breast oncological surgery were not performed during the highest peak of COVID-19 transmission (23). As an unexpected stressor for health care facilities, COVID-19 required urgent publication of temporary guidelines and fast change in clinical daily practice (20,24,25). Most of the countries adopted lockdown measures that required physicians to embrace innovative solutions such as telehealth applications and fast track protocols to sustain non-COVID-19 pathology treatments with limited resources, reducing the time spent in hospital (26-28). However, despite of economic, social, and health shock, COVID-19 seems to have a positive effect on the environment, through improvement in air quality, reduction in GHG emission, and mitigation of other pollutants due to the reduced human mobility (29). Even the health care industry was not immune to this effect; a monocentric study demonstrated how strong telehealth application in postoperative setting may reduce GHG emission due to reduction in patient transportation without a higher postoperative complication rate, but with a high patient satisfaction (30).
In fact, the healthcare industry is the most important anthropic pollutant, and is responsible for 4.4.% of GHG global emission, 10% in US, and 25% in UK (31,32). If assumed as a single country, all the health care processes were classified as the fifth larger world emitter (33). Every year, over 1.7 million tons of plastic waste are produced by US healthcare industries and this value is likely to rise up due to the increase in single-use plastics (33). Among different specialties, surgery, surgical treatment, and surgical theatre are intense health care activities, requiring expensive equipment, sterilization, and a complex supply chain (32). It has been estimated that up to 70% of GHG from health care industries are produced in surgery rooms and that a single operation may produce between 6 kg and 814 kg carbon dioxide equivalent (CO2e), the same amount of CO2e produced by an average petrol car traveling 2,273 miles. Anesthetic gases, consumable supply chain, and electricity usage are the major carbon emitters, requiring to rethink the surgical daily process (34,35).
Human health and environment health are strongly interdependent, but if the direct effect of climate change on public healthcare has been largely described in the text, physicians should be aware that the same connection may be found between health care policy and climate change (34). As displayed in Figure 1, aging of the population, innovation in health care, and rise of chronic diseases are expected to increase health care demands especially in low HDI countries in the future, increasing the healthcare GHG emission and having detrimental effects on the environment and therefore global health. Under this perspective, health care providers must be aware than every single action during their daily clinical practice may have a long-lasting effect on climate change and future health care policy. Starting from this new sensibility, several authors began to explore several strategies to reduce the carbon footprint of care in various clinical settings (31,33-38). For instance, regarding surgical procedure, while waste reduction, recycling, and segregation are well-known simple and easy applicable measures, the balance between single-use and reusable materials need to be further investigated (35). Moreover, modern anesthetic gas management is a neglected cause of GHG emission in the atmosphere, which can determine a small, but significative impact on yearly GHG emission (39). Finally, smart controlled surgery rooms may increase hospital efficiency in terms of heating, ventilation, and air conditioning (HVAC). In fact, HVAC energy systems are responsible for 90-99% of the overall energy used in surgical rooms, and its rationalization on occupancy-based ventilation strategies may reduce unnecessary airflow and up to 50% of energy costs.
Figure 1. Relationship between healthcare demands, climate change, and the role of improving sustainability.
Considering these data is the opinion of the authors that there is need for a revolution in the way of thinking delivery of care, addressing clinical outcomes, patient reported outcome measures (PROM), and environmental impact. Environment related outcome measures (EROM) as carbon footprint or GHG emission should be introduced in clinical trials to determine a clinical pathway with the highest clinical standard and a reduced impact of care on climate change, for instance combining innovation of tissue engineering in transplantation and sustainability or evaluating mini-invasive techniques in terms of GHG emissions and carbon footprint (30,40,41). Physician and health care workers should be aware that health systems worldwide are implementing (e.g., delivering a net zero NHS by England NHS) zero-carbon programs to reduce their carbon footprint (42).
Under this perspective, breast cancer (BC) may represent a model disease where different strategies may be easily applied for many reasons. First, BC is the leading oncological diagnosis worldwide with more than 2 million women are diagnosed, yearly (43,44). In fact, breast surgery, due to the high number of procedures yearly and the short surgical room occupancy, is a notable contributor to this environmental and subsequent financial burden (e.g., prosthetic surgery) (45). Paradigmatic shift and preoperative marker evaluation in breast cancer care (46-48) has allowed a reduction in surgical impact, ensuring a de-escalation of surgery while maintaining oncological safety, providing a model for a replicable, awake, and fast surgery, which could be easily studied as a model disease to implement EROM in clinical trials and to evaluate treatment efficacy (49). Following calculation of the carbon footprint of different breast cancer surgeries, our research group aims at proving breast cancer care green protocols (Green Breast Surgery) to obtain an evidence-based protocol, which could reduce the carbon footprint of BC care with non-inferior oncological and non-oncological outcomes.
Conflicts of Interest
The Authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Authors’ Contributions
Conceptualization: Oreste Claudio Buonomo, Gianluca Vanni, Marco Materazzo. Data curation: Marco Pellicciaro, Davide Marino Investigation: Oreste Claudio Buonomo, Marco Materazzo, Gianluca Vanni. Writing – original draft: Marco Materazzo and Oreste Claudio Buonomo. Writing –- review and editing: Gianluca Vanni. All Authors read and agreed to the submitted version of the article.
References
- 1.Kogan F. Causes of Climate Warming. Remote Sensing Land Surface. 2023;Changes:149–179. doi: 10.1007/978-3-030-96810-6_6. [DOI] [Google Scholar]
- 2.European Council Paris Agreement on climate change - Consilium, 2020. Available at: https://www.consilium.europa.eu/en/policies/climate-change/paris-agreement/ [Last accessed on March 27, 2023]
- 3.United Nations Sustainable Development Goals | United Nations Development Programme. United Nations Dev Program, 2021. Available at: https://www.undp.org/arab-states/sustainabledevelopment-goals. [Last accessed on May 4, 2023]
- 4.Landrigan PJ, Fuller R, Acosta NJR, Adeyi O, Arnold R, Basu NN, Baldé AB, Bertollini R, Bose-O’Reilly S, Boufford JI, Breysse PN, Chiles T, Mahidol C, Coll-Seck AM, Cropper ML, Fobil J, Fuster V, Greenstone M, Haines A, Hanrahan D, Hunter D, Khare M, Krupnick A, Lanphear B, Lohani B, Martin K, Mathiasen KV, McTeer MA, Murray CJL, Ndahimananjara JD, Perera F, Potočnik J, Preker AS, Ramesh J, Rockström J, Salinas C, Samson LD, Sandilya K, Sly PD, Smith KR, Steiner A, Stewart RB, Suk WA, van Schayck OCP, Yadama GN, Yumkella K, Zhong M. The Lancet Commission on pollution and health. Lancet. 2018;391(10119):462–512. doi: 10.1016/S0140-6736(17)32345-0. [DOI] [PubMed] [Google Scholar]
- 5.Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo OC. Breast cancer diagnosis in Coronavirus-era: Alert from Italy. Front Oncol. 2020;10:938. doi: 10.3389/fonc.2020.00938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Romanello M, Di Napoli C, Drummond P, Green C, Kennard H, Lampard P, Scamman D, Arnell N, Ayeb-Karlsson S, Ford LB, Belesova K, Bowen K, Cai W, Callaghan M, Campbell-Lendrum D, Chambers J, van Daalen KR, Dalin C, Dasandi N, Dasgupta S, Davies M, Dominguez-Salas P, Dubrow R, Ebi KL, Eckelman M, Ekins P, Escobar LE, Georgeson L, Graham H, Gunther SH, Hamilton I, Hang Y, Hänninen R, Hartinger S, He K, Hess JJ, Hsu SC, Jankin S, Jamart L, Jay O, Kelman I, Kiesewetter G, Kinney P, Kjellstrom T, Kniveton D, Lee JKW, Lemke B, Liu Y, Liu Z, Lott M, Batista ML, Lowe R, MacGuire F, Sewe MO, Martinez-Urtaza J, Maslin M, McAllister L, McGushin A, McMichael C, Mi Z, Milner J, Minor K, Minx JC, Mohajeri N, Moradi-Lakeh M, Morrissey K, Munzert S, Murray KA, Neville T, Nilsson M, Obradovich N, O’Hare MB, Oreszczyn T, Otto M, Owfi F, Pearman O, Rabbaniha M, Robinson EJZ, Rocklöv J, Salas RN, Semenza JC, Sherman JD, Shi L, Shumake-Guillemot J, Silbert G, Sofiev M, Springmann M, Stowell J, Tabatabaei M, Taylor J, Triñanes J, Wagner F, Wilkinson P, Winning M, Yglesias-González M, Zhang S, Gong P, Montgomery H, Costello A. The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels. Lancet. 2022;400(10363):1619–1654. doi: 10.1016/S0140-6736(22)01540-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ballanti F, Lione R, Fiaschetti V, Fanucci E, Cozza P. Low-dose CT protocol for orthodontic diagnosis. Eur J Paediatr Dent. 2008;9(2):65–70. [PubMed] [Google Scholar]
- 8.Shoham MA, Baker NM, Peterson ME, Fox P. The environmental impact of surgery: A systematic review. Surgery. 2022;172(3):897–905. doi: 10.1016/j.surg.2022.04.010. [DOI] [PubMed] [Google Scholar]
- 9.Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E. Environmental and health impacts of air pollution: a review. Front Public Health. 2020;8:14. doi: 10.3389/fpubh.2020.00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349. doi: 10.4061/2011/495349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hoffmann B, Moebus S, Möhlenkamp S, Stang A, Lehmann N, Dragano N, Schmermund A, Memmesheimer M, Mann K, Erbel R, Jöckel KH, Heinz Nixdorf Recall Study Investigative Group Residential exposure to traffic is associated with coronary atherosclerosis. Circulation. 2007;116(5):489–496. doi: 10.1161/CIRCULATIONAHA.107.693622. [DOI] [PubMed] [Google Scholar]
- 12.Bourdrel T, Bind MA, Béjot Y, Morel O, Argacha JF. Cardiovascular effects of air pollution. Arch Cardiovasc Dis. 2017;110(11):634–642. doi: 10.1016/j.acvd.2017.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Calderón-Garcidueñas L, Azzarelli B, Acuna H, Garcia R, Gambling TM, Osnaya N, Monroy S, DEL Tizapantzi MR, Carson JL, Villarreal-Calderon A, Rewcastle B. Air pollution and brain damage. Toxicol Pathol. 2002;30(3):373–389. doi: 10.1080/01926230252929954. [DOI] [PubMed] [Google Scholar]
- 14.Genc S, Zadeoglulari Z, Fuss SH, Genc K. The adverse effects of air pollution on the nervous system. J Toxicol. 2012;2012:782462. doi: 10.1155/2012/782462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hiatt RA, Beyeler N. Cancer and climate change. Lancet Oncol. 2020;21(11):e519–e527. doi: 10.1016/S1470-2045(20)30448-4. [DOI] [PubMed] [Google Scholar]
- 16.Booth M. Climate change and the neglected tropical diseases. Adv Parasitol. 2018;100:39–126. doi: 10.1016/bs.apar.2018.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, Olival KJ, Ross N, Bansal S. Climate change increases cross-species viral transmission risk. Nature. 2022;607(7919):555–562. doi: 10.1038/s41586-022-04788-w. [DOI] [PubMed] [Google Scholar]
- 18.Rizza S, Coppeta L, Grelli S, Ferrazza G, Chiocchi M, Vanni G, Bonomo OC, Bellia A, Andreoni M, Magrini A, Federici M. High body mass index and night shift work are associated with COVID-19 in health care workers. J Endocrinol Invest. 2021;44(5):1097–1101. doi: 10.1007/s40618-020-01397-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Vanni G, Legramante JM, Pellicciaro M, DE Carolis G, Cotesta M, Materazzo M, Buonomo C, Farinaccio A, Santori F, Saraceno F, Ielpo B, Aiello F, Paganelli C, Grande M, DE Andreis G, Chiocchi M, Palombi L, Buonomo OC. Effect of lockdown in surgical emergency accesses: Experience of a COVID-19 hospital. In Vivo. 2020;34(5):3033–3038. doi: 10.21873/invivo.12137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Buonomo OC, Materazzo M, Pellicciaro M, Caspi J, Piccione E, Vanni G. Tor Vergata university-hospital in the beginning of COVID-19-era: Experience and recommendation for breast cancer patients. In Vivo. 2020;34(3 Suppl):1661–1665. doi: 10.21873/invivo.11958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Vanni G, Materazzo M, Pellicciaro M, Ingallinella S, Rho M, Santori F, Cotesta M, Caspi J, Makarova A, Pistolese CA, Buonomo OC. Breast cancer and COVID-19: The effect of fear on patients’ decision-making process. In Vivo. 2020;34(3 Suppl):1651–1659. doi: 10.21873/invivo.11957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Vanni G, Materazzo M, Dauri M, Farinaccio A, Buonomo C, Portarena I, Pellicciaro M, Legramante JM, Rizza S, Chiaramonte C, Bellia A, Grande M, Potenza S, Sbordone FP, Perrone MA, Grimaldi F, Chiocchi M, Buonomo OC. Lymphocytes, interleukin 6 and D-dimer cannot predict clinical outcome in Coronavirus cancer patients: LyNC1.20 study. Anticancer Res. 2021;41(1):307–316. doi: 10.21873/anticanres.14777. [DOI] [PubMed] [Google Scholar]
- 23.De Rosa S, Spaccarotella C, Basso C, Calabrò MP, Curcio A, Filardi PP, Mancone M, Mercuro G, Muscoli S, Nodari S, Pedrinelli R, Sinagra G, Indolfi C, Società Italiana di Cardiologia and the CCU Academy investigators group Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083–2088. doi: 10.1093/eurheartj/ehaa409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Vergano M, Bertolini G, Giannini A, Gristina GR, Livigni S, Mistraletti G, Riccioni L, Petrini F. Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic. Crit Care. 2020;24(1):165. doi: 10.1186/s13054-020-02891-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wu F, Song Y, Zeng HY, Ye F, Chen B, Rong WQ, Wang LM, Niu LJ, Wu JX. [Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19] Zhonghua Zhong Liu Za Zhi. 2020;42(3):187–191. doi: 10.3760/cma.j.cn112152-20200227-00137. [DOI] [PubMed] [Google Scholar]
- 26.Vanni G, Materazzo M, Pellicciaro M, Caspi J, Capacci A, Merra G. Access to health care after COVID-19 pandemic: is it time for telemedicine. Eur Rev Med Pharmacol Sci. 2020;24(19):9778–9779. doi: 10.26355/eurrev_202010_23185. [DOI] [PubMed] [Google Scholar]
- 27.Society of Surgical Oncology Resource for Management Options of Breast Cancer During COVID-19, 2020. Available at: https://www.surgonc.org/wp-content/uploads/2020/03/Breast-Resource-during-COVID-19-3.30.20.pdf. [Last accessed April 6, 2020]
- 28.Vanni G, Pellicciaro M, Materazzo M, Dauri M, D’angelillo RM, Buonomo C, De Majo A, Pistolese C, Portarena I, Mauriello A, Servadei F, Giacobbi E, Chiaravalloti A, Buonomo OC. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer. 2021;28(1):137–144. doi: 10.1007/s12282-020-01137-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rita E, Chizoo E, Cyril US. Sustaining COVID-19 pandemic lockdown era air pollution impact through utilization of more renewable energy resources. Heliyon. 2021;7(7):e07455. doi: 10.1016/j.heliyon.2021.e07455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Materazzo M, Facchini A, Garozzo D, Buonomo C, Pellicciaro M, Vanni G. Maintaining good practice in breast cancer management and reducing the carbon footprint of care: study protocol and preliminary results. World Cancer Res J. 2022;9:e2438. doi: 10.32113/wcrj_202211_2438. [DOI] [Google Scholar]
- 31.MacNeill AJ, Lillywhite R, Brown CJ. The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems. Lancet Planet Health. 2017;1(9):e381–e388. doi: 10.1016/S2542-5196(17)30162-6. [DOI] [PubMed] [Google Scholar]
- 32.Chung JW, Meltzer DO. Estimate of the carbon footprint of the US health care sector. JAMA. 2009;302(18):1970–1972. doi: 10.1001/jama.2009.1610. [DOI] [PubMed] [Google Scholar]
- 33.Shoham MA, Baker NM, Peterson ME, Fox P. The environmental impact of surgery: A systematic review. Surgery. 2022;172(3):897–905. doi: 10.1016/j.surg.2022.04.010. [DOI] [PubMed] [Google Scholar]
- 34.Rizan C, Reed M, Mortimer F, Jones A, Stancliffe R, Bhutta M. Using surgical sustainability principles to improve planetary health and optimise surgical services following the COVID-19 pandemic. The Bulletin of the Royal College of Surgeons of England. 2020;102(5):177–181. doi: 10.1308/rcsbull.2020.148. [DOI] [Google Scholar]
- 35.Pradere B, Mallet R, de La Taille A, Bladou F, Prunet D, Beurrier S, Bardet F, Game X, Fournier G, Lechevallier E, Meria P, Matillon X, Polguer T, Abid N, De Graeve B, Kassab D, Mejean A, Misrai V, Pinar U, Sustainability Task Force of the French Association of Urology Climate-smart actions in the operating theatre for improving sustainability practices: a systematic review. Eur Urol. 2023;83(4):331–342. doi: 10.1016/j.eururo.2022.01.027. [DOI] [PubMed] [Google Scholar]
- 36.Bortoluzzi F, Sorge A, Vassallo R, Montalbano LM, Monica F, La Mura S, Canova D, Checchin D, Fedeli P, Marmo R, Elli L, Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO) Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO) Dig Liver Dis. 2022;54(12):1623–1629. doi: 10.1016/j.dld.2022.08.018. [DOI] [PubMed] [Google Scholar]
- 37.Morris DS, Wright T, Somner JE, Connor A. The carbon footprint of cataract surgery. Eye (Lond) 2013;27(4):495–501. doi: 10.1038/eye.2013.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bravo D, Gaston RG, Melamed E. Environmentally responsible hand surgery: past, present, and future. J Hand Surg Am. 2020;45(5):444–448. doi: 10.1016/j.jhsa.2019.10.031. [DOI] [PubMed] [Google Scholar]
- 39.Vollmer M, Rhee T, Rigby M, Hofstetter D, Hill M, Schoenenberger F, Reimann S. Modern inhalation anesthetics: Potent greenhouse gases in the global atmosphere. Geophysical Research Letters. 2019;42(5):1606–1611. doi: 10.1002/2014GL062785. [DOI] [Google Scholar]
- 40.Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G. Prospect for kidney bioengineering: shortcomings of the status quo. Expert Opin Biol Ther. 2015;15(4):547–558. doi: 10.1517/14712598.2015.993376. [DOI] [PubMed] [Google Scholar]
- 41.Ambrogi V, Forcella D, Gatti A, Vanni G, Mineo TC. Transthoracic repair of Morgagni’s hernia: a 20-year experience from open to video-assisted approach. Surg Endosc. 2007;21(4):587–591. doi: 10.1007/s00464-006-9017-7. [DOI] [PubMed] [Google Scholar]
- 42.NHS Delivering a “Net Zero” National Health Service Classification: Official, 2022. Available at: https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/#:~:text=On%201%20July%202022%2C%20the,now%20issued%20as%20statutory%20guidance. [Last accessed on April 6, 2023]
- 43.Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi: 10.1016/j.breast.2022.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dimitrov G, Atanasova M, Popova Y, Vasileva K, Milusheva Y, Troianova P. Molecular and genetic subtyping of breast cancer: the era of precision oncology. World Cancer Res J. 2022;9:e2367. doi: 10.32113/wcrj_20227_2367. [DOI] [Google Scholar]
- 45.Buonomo OC, Morando L, Materazzo M, Vanni G, Pistilli G, Palla L, Di Pasquali C, Petrella G. Comparison of round smooth and shaped micro-textured implants in terms of quality of life and aesthetic outcomes in women undergoing breast reconstruction: a single-centre prospective study. Updates Surg. 2020;72(2):537–546. doi: 10.1007/s13304-020-00721-w. [DOI] [PubMed] [Google Scholar]
- 46.Buonomo OC, Grasso A, Pistolese CA, Anemona L, Portarena I, Meucci R, Morando L, Deiana C, Materazzo M, Vanni G. Evaluation of concordance between histopathological, radiological and biomolecular variables in breast cancer neoadjuvant treatment. Anticancer Res. 2020;40(1):281–286. doi: 10.21873/anticanres.13950. [DOI] [PubMed] [Google Scholar]
- 47.Ferroni P, Palmirotta R, Spila A, Martini F, Formica V, Portarena I, Del Monte G, Buonomo O, Roselli M, Guadagni F. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer. Oncology. 2006;71(3-4):176–184. doi: 10.1159/000106072. [DOI] [PubMed] [Google Scholar]
- 48.Ferroni P, Roselli M, Spila A, D’Alessandro R, Portarena I, Mariotti S, Palmirotta R, Buonomo O, Petrella G, Guadagni F. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients. Cancer. 2010;116(12):2913–2921. doi: 10.1002/cncr.25094. [DOI] [PubMed] [Google Scholar]
- 49.Buonomo O, Granai AV, Felici A, Piccirillo R, De Liguori Carino N, Guadagni F, Polzoni M, Mariotti S, Cipriani C, Simonetti G, Cossu E, Schiaroli S, Altomare V, Cabassi A, Pernazza E, Casciani CU, Roselli M. Day-surgical management of ductal carcinoma in situ (DCIS) of the breast using wide local excision with sentinel node biopsy. Tumori. 2002;88(3):S48–S49. doi: 10.1177/030089160208800342. [DOI] [PubMed] [Google Scholar]
- 50.Morse S. Human Development Index. In: The Rise and Rise of Indicators. Stephen Morse (eds.) London, Routledge. 2019:pp. 61–81. [Google Scholar]